Anemia in the 1st Year of Life

Definition and Pathophysiology

• Defined as reduction in hemoglobin concentration, hematocrit, or red cell mass >2 standard deviations below mean for age and sex.
• Physiologic definition: Condition causing tissue hypoxia due to inadequate oxygen-carrying capacity of blood.
• Diagnosis heavily dependent on age-specific normal ranges; normal values vary substantially with age.
• High hemoglobin at birth declines progressively, establishing specific age-related thresholds for anemia.

Chronological Classification

Neonatal Anemia (Birth to 1 Month)

Hemorrhage (Acute or Chronic)

• Prenatal: Fetomaternal transplacental bleeding (spontaneous, traumatic amniocentesis), intraplacental bleeding, retroplacental abruption, or twin-to-twin transfusion syndrome.
• Twin-to-twin transfusion: Occurs in 15% of monochorionic twins; donor twin presents anemic, pale, with oligohydramnios.
• Intrapartum: Obstetric accidents, cord malformations, placental anomalies.
• Postnatal: Traumatic delivery causing intracranial/intra-abdominal hemorrhage, cephalhematoma, coagulation factor deficiencies, or severe thrombocytopenia.

Feature	Acute Blood Loss	Chronic Blood Loss
Clinical Presentation	Acute distress, pallor, tachycardia, rapid shallow respiration, shock, low blood pressure.	Marked pallor disproportionate to distress; possible congestive heart failure, hepatomegaly.
Hemoglobin at Birth	May be normal initially; drops quickly over first 24 hours.	Low at birth.
Red Cell Morphology	Normochromic, normocytic, or macrocytic.	Hypochromic, microcytic, anisocytosis, poikilocytosis.
Serum Iron	Normal at birth.	Low at birth.

Hemolysis

• Immune Isoimmunization: Rh, ABO, or minor blood groups (Kell, Duffy, Lutheran) incompatibility. Positive direct antiglobulin test (DAT).
• Congenital Erythrocyte Defects: Membrane defects (hereditary spherocytosis, elliptocytosis, infantile pyknocytosis). Enzyme defects (G6PD deficiency, pyruvate kinase deficiency).
• Hemoglobinopathies: Alpha-thalassemia syndromes (Hemoglobin Bart’s). Beta-thalassemia clinically silent at birth due to high fetal hemoglobin (HbF).
• Acquired Defects: Bacterial sepsis (E. coli, streptococcus), viral infections (CMV, rubella, herpes simplex), protozoal (toxoplasmosis), or metabolic causes (hypoxia, acidosis, vitamin E deficiency).

Hypoplasia (Failure of Production)

• Congenital Bone Marrow Failure: Diamond-Blackfan anemia, Fanconi anemia, Pearson syndrome, congenital dyserythropoietic anemia.
• Acquired: Viral infections (parvovirus B19, rubella, syphilis, CMV).

Anemias of 1 to 3 Months

Physiologic Anemia of Infancy

• Normal developmental response to extrauterine life; no hematologic problem.
• Pathophysiology: Onset of respiration increases oxygen saturation (50% to >95%). Replaces high-oxygen-affinity HbF with lower-affinity HbA, enhancing tissue oxygen delivery.
• Resulting hyperoxia down-regulates erythropoietin (EPO) production, suppressing erythropoiesis.
• Hemoglobin progressively declines over first 6-8 weeks.
• Nadir: 8-12 weeks; Hb ~11 g/dL, rarely falls below 10 g/dL in healthy term infants.
• Resolution: Occurs when tissue oxygen needs exceed delivery, stimulating EPO synthesis and resuming erythropoiesis.
• Treatment: No therapy required.

Anemia of Prematurity

• Exaggerated, rapid physiologic anemia in preterm infants.
• Nadir: 3-6 weeks; hemoglobin reaches 7-9 g/dL.
• Pathophysiology: Diminished EPO response (fetal liver oxygen sensor less sensitive than kidney). Shortened RBC lifespan (40-60 days). Rapid RBC mass expansion associated with growth. Exacerbated by frequent iatrogenic phlebotomy losses in neonatal intensive care.
• Clinical features: Tachycardia, tachypnea, increased apnea/bradycardia, poor weight gain.
• Management: Limit phlebotomy; iron supplementation (starting at 1 month); packed RBC transfusions for symptomatic infants. Recombinant human EPO (rHuEPO) use controversial due to inconsistent neurodevelopmental benefits and possible retinopathy risk.

Anemias of Late Infancy (3 to 12 Months)

Nutritional Anemias

• Iron Deficiency Anemia (IDA): Most common nutritional deficiency. Iron stores depleted by 6 months in term infants, 3-4 months in preterm infants.
  • Causes: Excessive cow’s milk intake, breastfeeding >6 months without iron supplementation, delayed weaning to iron-rich solid foods, prematurity.
  • Diagnosis: Microcytic, hypochromic anemia, elevated RDW, low ferritin, elevated total iron binding capacity (TIBC).
• Megaloblastic Anemia: Peak incidence 4-7 months for folate deficiency.
  • Causes: Goat’s milk diet (deficient in folate), maternal vitamin B12 deficiency (vegan/vegetarian diet) transferred via breast milk, intrinsic factor deficiency.
  • Diagnosis: Macrocytic red cells, hypersegmented neutrophils, megaloblastic bone marrow.

Hemoglobinopathies

• Beta-Thalassemia Major: Presents at 6-12 months. Symptoms appear postnatally as gamma-globin decreases and defective beta-globin production fails to compensate. Transfusion-dependent anemia, hepatosplenomegaly, frontal bossing.
• Sickle Cell Disease (HbSS): Asymptomatic at birth. Presents by 2-3 months with anemia, dactylitis, and splenic infarction as HbF levels fall.

Pure Red Cell Aplasias

• Diamond-Blackfan Anemia (DBA): Median age at diagnosis 3-4 months; >90% present in first year. Macrocytic anemia, reticulocytopenia, normal cellular marrow with absent erythroid precursors. Congenital anomalies present in 50% (craniofacial, thumb deformities).
• Transient Erythroblastopenia of Childhood (TEC): Most common acquired red cell aplasia. Typically presents in children >12 months, but can occur from 6 months. Preceded by viral illness. Normocytic anemia, reticulocytopenia, spontaneous recovery.

Diagnostic Approach

Clinical Evaluation

• Dietary history: Type of milk (cow’s milk vs. breast milk), age of solid food introduction, vegan diet.
• Obstetric/Perinatal history: Prematurity, maternal anemia, twin gestation, neonatal jaundice, birth asphyxia.
• Physical examination: Pallor (conjunctival, palmar), tachycardia, flow murmur, hepatosplenomegaly, congenital anomalies (radial limb defects in inherited marrow failure).

Laboratory Investigations

• Initial evaluation: Complete blood count (CBC), reticulocyte count, peripheral blood smear, RBC indices.
• Reticulocyte count dictates physiological classification:
  • Elevated (>3% index): Accelerated destruction (hemolysis) or blood loss.
  • Decreased (<1.5% index): Impaired production (nutritional deficiency, marrow failure, TEC).

MCV Classification	Low MCV (Microcytic)	Normal MCV (Normocytic)	High MCV (Macrocytic)
Low/Normal Reticulocyte	Iron deficiency, Thalassemia trait, Lead poisoning, Chronic disease.	TEC, Renal failure, Bone marrow infiltration, Infection.	Folate/B12 deficiency, DBA, Hypothyroidism, Down syndrome.
High Reticulocyte	Thalassemia syndromes.	Acute bleeding, Membrane defects (spherocytosis), Enzyme defects (G6PD), Hemoglobinopathies.	Active hemolysis (marked reticulocytosis), Dyserythropoietic anemia.

Peripheral Smear Finding	Associated Conditions
Spherocytes	Hereditary spherocytosis, ABO incompatibility, Autoimmune hemolytic anemia.
Schistocytes	Microangiopathic hemolytic anemia, Disseminated intravascular coagulation, Hemolytic uremic syndrome.
Target Cells	Thalassemia, Hemoglobin C disease, Liver disease, Post-splenectomy.
Heinz Bodies	Thalassemia, G6PD deficiency, Unstable hemoglobins.
Pyknocytes	Infantile pyknocytosis, Vitamin E deficiency.

Differentiating Feature	Diamond-Blackfan Anemia (DBA)	Transient Erythroblastopenia of Childhood (TEC)
Etiology	Genetic (inherited bone marrow failure).	Acquired (post-viral).
Age at Presentation	50% by 3 months; 90% by 1 year.	Usually >12 months (range 6 months to 4 years).
Physical Anomalies	Present in ~50% (thumb, cardiac, craniofacial).	Absent.
MCV	Increased at diagnosis (80%), high in remission.	Normal at diagnosis; increased only during recovery.
Fetal Hemoglobin (HbF)	Elevated.	Normal at diagnosis.
Erythrocyte ADA Activity	Elevated.	Normal.
Course	Prolonged, requires steroids/transfusion.	Spontaneous recovery in 1-2 months.

Management Strategies

Transfusion Guidelines (Infants <4 months)

• Use leukocyte-reduced, irradiated (in low birthweight infants), CMV-safe RBCs.
• Transfusion volume: 10-15 mL/kg infused slowly over 2-4 hours.

Clinical Scenario	Hemoglobin Transfusion Threshold
Severe pulmonary disease / ECMO	Maintain Hb >12.0 g/dL.
Severe cardiac disease	Maintain Hb >12.0 g/dL.
Moderate pulmonary disease	Maintain Hb >10.0 g/dL.
Major surgery (preoperative)	Maintain Hb >10.0 g/dL.
Symptomatic anemia / Postoperative	Maintain Hb >7.0 g/dL.

Nutritional Interventions

• Iron Prophylaxis:
  • Premature infants: 2 mg/kg/day elemental iron starting at 2-4 weeks of age, continuing until 1 year.
  • Exclusively breastfed infants: 1 mg/kg/day iron supplementation beginning at 4 months of age until solid foods meet requirements.
• Therapeutic Iron: For IDA, 3-6 mg/kg/day elemental iron once daily. Continue for 3-4 months post-correction to replenish stores.
• Folic Acid: Supplement in patients on goat’s milk diets, chronic hemolysis (e.g., sickle cell, hereditary spherocytosis), or prematurity.